ExpreS2ion Biotechnologies - Presentation of Q2 2025 report (Recording)
21 augusti, 13:19
21 augusti, 13:19
Today, ExpreS2ion Biotechnologies’ management presented the results for the second quarter of 2025, provided further insights into the recent pipeline developments, and shared the latest updates on partnerships aimed at commercializing the company’s technology platform.
21 augusti, 13:19
Today, ExpreS2ion Biotechnologies’ management presented the results for the second quarter of 2025, provided further insights into the recent pipeline developments, and shared the latest updates on partnerships aimed at commercializing the company’s technology platform.
Konjunkturprognoser
Privatekonomi
Novo Nordisk
Saabs miljardaffär
Konjunkturprognoser
Privatekonomi
Novo Nordisk
Saabs miljardaffär
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 656,85